Avidity Partners Management’s IDEAYA Biosciences IDYA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-445,000
| Closed | -$7.29M | – | 66 |
|
2025
Q1 | $7.29M | Sell |
445,000
-681,700
| -61% | -$11.2M | 1.39% | 29 |
|
2024
Q4 | $29M | Sell |
1,126,700
-246,300
| -18% | -$6.33M | 2.84% | 10 |
|
2024
Q3 | $43.5M | Buy |
1,373,000
+256,000
| +23% | +$8.11M | 2.22% | 13 |
|
2024
Q2 | $39.2M | Buy |
1,117,000
+317,300
| +40% | +$11.1M | 1.67% | 23 |
|
2024
Q1 | $35.1M | Sell |
799,700
-720,300
| -47% | -$31.6M | 1.13% | 32 |
|
2023
Q4 | $54.1M | Sell |
1,520,000
-624,971
| -29% | -$22.2M | 1.97% | 17 |
|
2023
Q3 | $57.9M | Sell |
2,144,971
-840,729
| -28% | -$22.7M | 2.33% | 9 |
|
2023
Q2 | $70.2M | Sell |
2,985,700
-687,700
| -19% | -$16.2M | 2.45% | 7 |
|
2023
Q1 | $50.4M | Sell |
3,673,400
-151,400
| -4% | -$2.08M | 1.67% | 23 |
|
2022
Q4 | $69.5M | Buy |
3,824,800
+109,400
| +3% | +$1.99M | 1.51% | 23 |
|
2022
Q3 | $55.4M | Buy |
3,715,400
+742,453
| +25% | +$11.1M | 1.13% | 32 |
|
2022
Q2 | $41M | Buy |
2,972,947
+282,947
| +11% | +$3.9M | 0.94% | 31 |
|
2022
Q1 | $30.1M | Buy |
2,690,000
+137,000
| +5% | +$1.53M | 0.63% | 40 |
|
2021
Q4 | $60.4M | Buy |
2,553,000
+116,000
| +5% | +$2.74M | 1.28% | 29 |
|
2021
Q3 | $62.1M | Buy |
2,437,000
+367,000
| +18% | +$9.35M | 1.38% | 26 |
|
2021
Q2 | $43.4M | Buy |
2,070,000
+598,000
| +41% | +$12.6M | 1.17% | 31 |
|
2021
Q1 | $34.6M | Buy |
+1,472,000
| New | +$34.6M | 0.96% | 37 |
|
2020
Q4 | – | Sell |
-1,050,800
| Closed | -$13.2M | – | 107 |
|
2020
Q3 | $13.2M | Sell |
1,050,800
-280,300
| -21% | -$3.52M | 0.61% | 42 |
|
2020
Q2 | $18.9M | Buy |
+1,331,100
| New | +$18.9M | 1.21% | 33 |
|